Functional Dissection of the Mechanism that Lead to Loss of Somatic Cell Identity
Functional Dissection of the Mechanism that Lead to Loss of Somatic Cell Identity
批准号:
9148350
负责人:
Bernadett Papp
金额:
$7.63万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-01-06 至 2018-12-31
关键词:
AdultAlpha CellBehaviorBindingBinding SitesBiological ModelsCell Differentiation processCellsDataDevelopmentDevelopmental ProcessDiseaseDissectionEmbryonic DevelopmentEnhancersEpigenetic ProcessFoundationsGenerationsGenesGenomeGenomicsGoalsIn VitroLeadLinkLocationMaintenanceMediatingMedicalMethodsNucleic Acid Regulatory SequencesPathway interactionsPatientsPlayPopulationProcessRegulator GenesReplacement TherapyRepressionRoleSignal PathwaySignal TransductionSiteSomatic CellStem cellsT cell factor 3TestingTherapeuticTranscription Repressor/CorepressorWNT Signaling PathwayWorkbasec-myc Genescell typedesignembryonic stem cellepigenomegenome-widein vitro Modelinduced pluripotent stem cellinhibitor/antagonistoverexpressionsmall moleculesmall molecule librariestranscription factortranscriptome
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
Adult cells can be forced to change their cell identity and reprogrammed to an embryonic stem cell (ESC)-like
induced pluripotent stem cells (iPSCs) state. Reprogramming to iPSCs can be achieved by overexpression of
the four transcription factors (TFs) Oct4, Sox2, Klf4, and cMyc (OSKM). Reprogramming takes 2 weeks and
the iPSCs are generally derived from less than 1% of the starting cell population. However, the reprogramming
is more efficient when we modulate the activity of signaling pathways with small molecule activators or
inhibitors. In this regard, we have recently demonstrated that the stepwise-modulation of the Wnt signaling
pathway and its downstream transcriptional factors (Tcf1, Tcf3, Tcf4 and Lef1) during different stages of
reprogramming promotes the establishment of iPSCs. Our studies also highlight that reprogramming of
somatic cells provides a powerful in vitro model system for studying the signaling mechanisms underlying cell
fate changes. Importantly, we still do not know how Wnt pathway and other signaling pathways act in somatic
cells and limit the various stages of reprogramming. Current understanding of cell fates emphasize that not
only the proper set of genes has to be expressed, but also the correct gene regulatory regions have to be
engaged by cell type specific TFs and epigenetic markings. Signaling pathway TFs that are often expressed in
a cell type specific manner must be targeted to their proper locations in order to maintain cell identity or to
create new cell fates upon signal stimulation, however their targeting mechanisms are largely unknown. Our
preliminary data show that the Wnt signaling TF Tcf3 dynamically changes its genome-wide binding during
reprogramming. By studying this stage-specific behavior of Tcf3, we revealed a previously unknown early
barrier of reprogramming, which controls the erasure of somatic Tcf3 sites and the generation of its new
reprogramming sites. In this proposal, we will study the role of our newly identified reprogramming-inhibiting
TFs as regulators of Tcf3 binding. Furthermore, we propose to identify signaling pathways, which maintain the
somatic cell identity and control reprogramming in a stage specific manner. Using our new single cell level
immunostaining method, we will determine how these signaling pathways regulate the distinct cell fates during
reprogramming. We believe that our work will ultimately lead to (i) a better understanding of how specific cell
fates are maintained by signaling pathways, and (ii) also help identifying critical signaling pathways that act
during specific cell fate changes. Signaling pathways control many cell fate choices during development and
their deregulation can cause diseases. Therefore, understanding the role of signaling pathways in maintaining
somatic state and regulating the loss of somatic identity is crucial so that we can modulate these signaling
pathways to create or maintain desired cell fates.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Immune evasion mechanisms by a tumor herpesvirus in the oral cavity
-
批准号:10308124
-
项目类别:
-
资助金额:$36.22万
-
财政年份:2020
-
负责人:Bernadett Papp
-
依托单位:
Immune evasion mechanisms by a tumor herpesvirus in the oral cavity
-
批准号:10521292
-
项目类别:
-
资助金额:$36.22万
-
财政年份:2020
-
负责人:Bernadett Papp
-
依托单位:
海外基金